|
⚲
|
| Keyboard |
| Lauren Otsuki | |
|---|---|
| Firm | |
| Address | 5601 Oberlin Drive, Suite 100 San Diego, CA 92121 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| SRT Therapeutics Inc | 021-554665 | Executive Officer | 47.4 M of 47.5 M |
||
| Evida Biosciences Inc | 021-526564 | Director | 42.0 M of 42.0 M |
||
| GLO Pharma Inc | 021-413342 | Director | 53.0 M of 53.0 M |
||
| GLO Pharma Inc | 021-381523 | Director | 6.8 M of 6.8 M |
||
| GLO Pharma Inc | 021-381518 | Director | 0.5 M of 0.5 M |
||
| Prometheus Biosciences Inc | 021-380262 | Executive Officer | 50.0 M of 130.0 M |
||
| Prometheus Biosciences Inc | 021-344258 | Executive Officer | 48.1 M of 60.0 M |
||
| Oncternal Therapeutics Inc | 021-326302 | Executive Officer | 17.0 M of 24.0 M |
||
| Oncternal Therapeutics Inc | 021-295508 | Executive Officer | 6.9 M of 11.3 M |
||
| Oncternal Therapeutics Inc | 021-266615 | Executive Officer | 0.1 M of 3.3 M |
||
| Oncternal Therapeutics Inc | 021-264575 | Executive Officer | 13.1 M of 13.1 M |
||
| Oncternal Therapeutics Inc | 021-245323 | Executive Officer | 17.9 M of 23.5 M |
||
| Selexagen Therapeutics Inc | 021-151616 | Executive Officer | 0.6 M of 0.6 M |
||